Volume 2, Issue 7: Safety of the Newer Oral Diabetes Treatment Agents

e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 2, Issue 7)

Target Audience

Nurses and health care professionals involved in the care of patients with diabetes.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to describe new findings in:

  • Identify the safety issues that affect selection criteria for treating patients with type 2 diabetes with GLP-1 receptor agonists.
  • Identify the safety issues that affect selection criteria for treating patients with type 2 diabetes with DPP-4 inhibitors.
  • Identify the safety issues that affect selection criteria for treating patients with type 2 diabetes with SGLT-2 inhibitors.
Additional information
Contact email: 
Course summary
Available credit: 
  • 0.50 ANCC
  • 0.50 Attendance
Course opens: 
02/25/2016
Course expires: 
02/24/2018
Cost:
$0.00
Marc Rendell, MD
Professor of Medicine
Creighton University School of Medicine
Director, Creighton Diabetes Center
Creighton University Medical Center
Omaha, Nebraska
 

Available Credit

  • 0.50 ANCC
  • 0.50 Attendance

Accreditation Period

Course opens: 
02/25/2016
Course expires: 
02/24/2018

Price

Cost:
$0.00
Please login or register to take this course.